You might also like
Veralto is a company that operates through two main segments, focusing on enhancing water and product quality. The Water Quality segment aims to improve water quality and reliability through brands like Hach, Trojan Technologies, and ChemTreat, while the Product Quality & Innovation segment enhances consumer trust and product innovation with brands such as Videojet, Linx, Esko, X-Rite, and Pantone . In 2023, Veralto generated $5.0 billion in sales, with a significant portion derived from consumables, spare parts, services, and software, indicating a strong recurring revenue model . The company maintains a resilient financial performance across economic cycles due to its business model, which supports a strong margin profile with limited capital expenditure requirements .
- Water Quality (WQ) - Focuses on improving the quality and reliability of water through brands like Hach, Trojan Technologies, and ChemTreat, offering solutions for water analysis, treatment, and management.
- Product Quality & Innovation (PQI) - Promotes consumer trust and product innovation through brands such as Videojet, Linx, Esko, X-Rite, and Pantone, providing solutions for product identification, packaging, and color management.
What went well
- Veralto's simplification and enhancement of the Veralto Enterprise System (VES) have fortified execution, driving discipline and focus, enabling the company to better capitalize on durable growth trends across both segments.
- The acquisition of TraceGains strengthens Veralto's position in food safety and traceability, enhancing capabilities to provide ingredient traceability and leveraging their coding and marking business to identify and quarantine contaminated products, addressing the growing demand for food safety solutions.
- Veralto is experiencing strong growth in Latin America, now representing 10% of total sales, propelled by investments in high-growth opportunities, benefits from reshoring/onshoring trends as customers diversify supply chains, and privatization of water utilities in Brazil, contributing to sustainable growth going forward.
What went wrong
- Limited Capabilities in Food-Borne Contamination Detection: Veralto admits they are less equipped to handle acute outbreaks of food-borne issues compared to water-borne outbreaks, stating "we don't play as heavily there."
- Margin Pressure in Water Quality Segment Due to Product Mix and Investments: The company acknowledges that the analytics business, which has higher margins, is being outpaced by growth in lower-margin industrial and chemical treatment businesses, impacting overall margins.
- Potential Risks Associated with M&A Strategy and Valuation: When questioned about entry multiples in M&A, the CFO emphasizes value creation over valuation discipline, which could imply risks in overpaying for acquisitions.
Q&A Summary
-
Q4 Margin Guidance
Q: Why is Q4 margin expected to be down versus Q3?
A: Margins in Q4 are projected to be lower due to a 30 basis point impact from TraceGains' operating impact and transaction costs , an additional 50 basis point impact from higher corporate costs related to first-year public company expenses , and a mix shift towards equipment sales as printer volumes recover. Combined, these factors contribute to an 80 basis point margin impact. -
Growth Outlook
Q: Any changes in growth trends for Q4 and into 2025?
A: Growth patterns are expected to be similar to Q3 , with steady recovery in the consumer packaged goods (CPG) sector. Demand remains consistent, and the company is encouraged by ongoing improvements in PQI. China is anticipated to be sequentially flat, but a strong Q4 last year may impact year-over-year comparisons. -
TraceGains Acquisition Impact
Q: How will TraceGains drive growth and affect earnings?
A: TraceGains provides cloud-based solutions connecting brands with ingredient manufacturers, enhancing compliance and traceability in food and beverage safety. It's expected to continue delivering double-digit sales growth. However, due to ongoing investments to fuel this growth, TraceGains is projected to be modestly dilutive to earnings in 2025. -
CPG Market Recovery
Q: What are the signs of recovery in the CPG market?
A: The company observes a fifth consecutive quarter of mid- to high single-digit growth in recurring revenue at PQI , indicating that production lines are coming back online and being refurbished. Additionally, there have been two consecutive quarters of year-over-year growth in equipment sales, suggesting brand owners are upgrading and replacing aging printers. -
China Sales Outlook
Q: What is the outlook for China sales?
A: China sales are expected to remain sequentially flat. There is modest recovery in PQI within CPG and industrial markets , but challenges persist in Water Quality due to funding issues at municipal customer sites and tough comparisons from strong semiconductor project sales last year. -
Latin America Growth
Q: Why has Latin America growth accelerated, and is it sustainable?
A: Growth in Latin America has accelerated due to commercial investments and focusing on high-growth opportunities. Benefits are seen from reshoring/onshoring activities as customers diversify risk from China. Also, privatization of water utilities in Brazil is providing new opportunities. Latin America now represents 10% of total sales, and the company believes this growth is sustainable. -
CapEx Requirements
Q: What are the long-term CapEx needs?
A: The business operates on an asset-light model, with CapEx typically at 1% to 2% of sales. Investments focus on R&D and commercial activities rather than capital expenditures. -
M&A Strategy and ROIC Targets
Q: What are the acquisition criteria and ROIC expectations?
A: The company focuses on market, company, and valuation alignment for acquisitions. For small bolt-on acquisitions, they aim to achieve cost of capital by year 3. For larger, technology-focused acquisitions like TraceGains, they target achieving ROIC close to cost of capital by year 5 or 6. -
Water Quality Margins
Q: What's affecting margins in the Water Quality segment?
A: Margins are influenced by a mix shift towards higher growth in industrial and chemical treatment businesses, which have slightly lower margins than analytics. Additionally, investments in sales and marketing are being made to capture future growth opportunities. -
Traceability Solutions
Q: How is the company positioned in food traceability?
A: The company's coding and marking business provides date codes and lot codes, enabling traceability to identify and quarantine affected products in the event of contamination. The integration of TraceGains enhances the ability to trace ingredient information, crucial for brand manufacturers.
Guidance Changes
Quarterly guidance for Q4 2024:
- Core Sales Growth: Low to mid-single-digit range (no prior guidance)
- Acquisitions Contribution: About 60 basis points (no prior guidance)
- Adjusted Operating Profit Margin: ~24% (no prior guidance)
- Adjusted EPS: $0.86 to $0.90 (no prior guidance)
Annual guidance for FY 2024:
- Adjusted EPS: $3.44 to $3.48 (raised from $3.37 to $3.45 )
- Given TraceGains is expected to be modestly dilutive to 2025 earnings due to planned investments, can you elaborate on what specific investments are required and how they will drive growth to achieve your double-digit ROI target by year six?
- With Latin America showing 10% core sales growth driven by factors like reshoring and privatization of water utilities, how sustainable is this growth, and what risks do you anticipate that could potentially slow down this momentum?
- You reported a 3% decline in sales into China; can you provide more insight into the underlying factors contributing to this decline and what strategies you have in place to address this market challenge?
- The PQI segment is experiencing a gradual U-shaped recovery rather than the V-shaped recoveries seen in the past; what are the key barriers preventing a faster rebound, and how are you addressing these to accelerate growth in this segment?
- In the context of your M&A strategy and the acquisition of TraceGains, how do you navigate paying high entry multiples while ensuring you meet your long-term ROI targets, especially given the competitive environment for high-quality assets?
Q3 2024 Earnings Call
- Issued Period: Q3 2024
- Guided Period: Q4 2024 and FY 2024
- Guidance:
- Core Sales Growth: Low to mid-single-digit range for Q4 2024.
- Acquisitions Contribution: About 60 basis points to year-over-year sales growth.
- Adjusted Operating Profit Margin: Approximately 24% for Q4 2024.
- Adjusted EPS for Q4 2024: Between $0.86 to $0.90 per share.
- Full Year Adjusted EPS Guidance: $3.44 to $3.48 per share, with an 8% year-over-year growth .
Q2 2024 Earnings Call
- Issued Period: Q2 2024
- Guided Period: Q3 2024 and FY 2024
- Guidance:
- Full Year 2024:
- Core Sales Growth: Low single digits, trending towards high end.
- Adjusted Operating Profit Margin: Approximately 75 basis points expansion, aiming for about 24%.
- Adjusted EPS: $3.37 to $3.45 per share, 7% growth.
- Free Cash Flow Conversion: 100% to 110% of GAAP net income.
- Q3 2024:
- Core Sales Growth: Low to mid-single digits.
- Adjusted Operating Profit Margin: Approximately 23.5%.
- Adjusted EPS: $0.82 to $0.86 per share .
- Full Year 2024:
Q1 2024 Earnings Call
- Issued Period: Q1 2024
- Guided Period: Q2 2024 and FY 2024
- Guidance:
- Full Year 2024:
- Core Sales Growth: Low single-digit growth.
- Price Contribution: 100 to 200 basis points.
- Adjusted Operating Profit Margin: 50 to 75 basis points improvement.
- Adjusted EPS: $3.25 to $3.34 per share.
- Free Cash Flow Conversion: 100% to 110%.
- Q2 2024:
- Core Sales Growth: Low single-digit growth.
- Adjusted Operating Margin: Approximately 23%.
- Adjusted EPS: $0.75 to $0.80 per share .
- Full Year 2024:
Q4 2023 Earnings Call
- Issued Period: Q4 2023
- Guided Period: Q1 2024 and FY 2024
- Guidance:
- Core Sales Growth: Low single digits.
- Price Contribution: 100 to 200 basis points.
- Corporate and Other Expense: About $100 million.
- Adjusted Operating Profit Margin: 50 to 75 basis points improvement.
- Adjusted EPS: $3.20 to $3.30 per share.
- Sequential Core Sales Growth: Improvement expected throughout 2024.
- Q1 2024 Specific:
- Core Sales: Approximately flat.
- Adjusted Operating Profit Margin: 23% to 23.5%.
- Adjusted EPS: $0.73 to $0.78 per share .